Share Prices & Company Research

Stockbroking

Advanced Oncotherapy

Current Price 46.25p Bid 46.00p Ask 48.00p Change 1.08%
Last Updated: 22/06/2018 20:10. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Advanced Oncotherapy plc (formerly CareCapital Group plc) is a provider of particle therapy with protons that harnesses the best in modern technology. Advanced Oncotherapy's team ADAM, based in Geneva, focuses on the development of a proprietary proton accelerator called Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control which is not achievable with older technologies. Advanced Oncotherapy will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology as well as lower treatment related side effects. Advanced Oncotherapy continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships, the Company will remain the prime provider of an innovative and cost-effective system for particle therapy with protons.

Financial Highlights Year Ended 31/12/2016

Turnover
£0.00m
Operating Profit
£-13.09m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-2.73

Key Personnel

Nicolas Serandour
Chief Operating Officer
Dr Michael Jeffrey Sinclair
Executive Chairman
Sanjeev Pandya
Executive Director
Michael Stephen Bradfield
Non-Executive Director
Prof Christopher Martin Nutting
Non-Executive Director
Dr Euan Stuart Thomson
Non-Executive Director
Enrico Cipro Vanni
Non-Executive Director
Dr Piers Nicholas Plowman
Non-Executive Director
Prof Stephen Myers
Non-Executive Director
Hans Henrik von Celsing
Non-Executive Director

Stock Details

EPIC
AVO
ISIN
GB00BD6SX109
Shares in Issue
155,629,233
Market cap
£72.37m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
47.00p
Bid Price
46.00p
Ask Price
48.00p
Volume
33130
Change Today
0.50p
% Change Today
1.08%
Open
46.00p
Previous Close
47.00p
Intraday High
47.00p
Intraday Low
46.00p
52 Week High
63.50p
52 Week Low
9.75p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Advanced Oncotherapy Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Tangible Assets
1.5
1.0
Intangible Assets & Goodwill
23.4
12.7
Investments & Other Non-Current Assets
0.3
0.3
Total Non-Current Assets
25.1
14.1
Inventory
7.4
4.4
Trade & Receivables
0.5
0.5
Cash & Receivables
1.5
9.0
Other Current Assets & Assets Held for Resale
3.2
2.8
Total Assets
37.7
30.7

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Short Term Liabilities
3.7
3.5
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
3.7
3.5

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Net Assets
34.0
27.3

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Share Capital
18.1
14.2
Minority Interests
0.0
0.0
Retained Earnings
-44.1
-33.7
Share Premium Account
43.1
32.8
Other Equity
16.8
14.0
Total Equity
34.0
27.3

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Cashflow from Operating Activities
-10.9
-9.9
Cashflow Before Financing
-20.6
-13.6
Increase / Decrease in Cash
-7.5
7.5

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2016
31 Dec 2015
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-13.1
-8.5
Pre-Tax Profit
-13.2
-8.6
Profit / Loss for the Year
-10.4
-6.6
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.